ADRA2C antibody (C-Term)
Quick Overview for ADRA2C antibody (C-Term) (ABIN2196828)
Target
See all ADRA2C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 353-382, C-Term
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- ADRA2C, CT (ADRA2C, ADRA2L2, ADRA2RL2, Alpha-2C adrenergic receptor, Alpha-2 adrenergic receptor subtype C4, Alpha-2C adrenoreceptor)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogen
- ADRA2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 353-382 amino acids from the C-terminal region of human ADRA2C.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Alternative Name
- ADRA2C
-
NCBI Accession
- NP_000674
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-